Cargando…
Retroperitoneal Metastasis, with Marked Fibrosis, of Lung Adenocarcinoma after Afatinib Treatment: An Autopsy Case Report
A 73-year-old woman was admitted to our hospital for treatment of vomiting. Four months previously, she had been diagnosed with lung adenocarcinoma (cT3N3M1a stage IVA) and started receiving afatinib as first-line treatment. On admission, the primary tumor had shrunk, but abdominal computed tomograp...
Autores principales: | Ota, Hiroki, Ota, Tomohiro, Narisawa, Eriko, Chiba, Hideyuki, Nakayama, Hiroshi, Tsukumo, Yoko, Sakamoto, Atsuhiko, Honma, Naoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725614/ https://www.ncbi.nlm.nih.gov/pubmed/32727983 http://dx.doi.org/10.2169/internalmedicine.4869-20 |
Ejemplares similares
-
Lung Adenocarcinoma Exhibiting A Butterfly Shadow Pattern
por: Ota, Hiroki, et al.
Publicado: (2021) -
A Case of Lung Adenocarcinoma with Marked Improvement of Pulmonary Lymphangitic Carcinomatosis by Adding Bevacizumab to Cisplatin and Pemetrexed
por: Natsume, Maika, et al.
Publicado: (2017) -
Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib
por: Sogawa, Rintaro, et al.
Publicado: (2019) -
Role of miR-143 and miR-146 in Risk Evaluation of Coronary Artery Diseases in Autopsied Samples
por: Tie, Jian, et al.
Publicado: (2023) -
Afatinib-Induced Acute Fatal Pneumonitis in Metastatic Lung Adenocarcinoma
por: Yoo, Sang Hoon, et al.
Publicado: (2016)